Athena peptide

It acts on three hormone pathways that regulate appetite, metabolism, and blood sugar: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon. By simultaneously activating these receptors, Athena reduces appetite, slows gastric emptying, and increases energy expenditure, making it more potent than single- or dual-agonist drugs like semaglutide or tirzepatide